Anti-IL11 therapies demonstrate beneficial effects in reducing the severity of disease in mice models of Alport syndrome. Affecting about one in every 50,000 newborns globally, Alport syndrome is a...
The collaboration will see novel therapeutic antibody discovery and CMC process development to produce more effective, safer and affordable treatments. Singapore-based SCG Cell Therapy Pte Ltd...
The Siemens Healthineers SARS-CoV-2 IgG Antibody Test, available under CE Mark, has proven to measure neutralizing antibodies. The company has submitted to the FDA under EUA. Siemens Healthineers...
With the rise of paradigm shifting healthcare challenges and the recent COVID-19 pandemic, healthcare systems need to embrace new technologies to boost efficiency and improve quality of care for its...
The SARS-CoV-2 surrogate virus neutralisation test (sVNT) was the fruit of collaborative efforts among Duke-NUS Medical School, NCID, A*STAR IMCB and GenScript Biotech. Its high specificity and...
LUNAR-COV19, a new COVID-19 vaccine candidate developed by Arcturus Therapeutics Holdings Inc. and Duke-NUS Medical School, could produce immunity at low doses, even only after a single...
A potential post-infection antibody treatment for yellow fever, named TY014, was devised by a multi-disciplinary research team at SMART. TY014 could complement vaccination efforts and reduce the risk...
Innovative biotherapeutics company, Hummingbird Bioscience announced a partnership with Mycenax Biotech to produce anti-VISTA antibody, HMBD-002 for use in Phase I clinical trials of its HMBD-002...
In early January 2020, Hummingbird Bioscience published preclinical data showcasing the efficacy of its anti-HER3 antibody known as HMBD-001 (also known as 10D1F.1) The findings demonstrate the...
Hummingbird Bioscience published in January 2020 preclinical data of its lead candidate, HMBD-001, in Molecular Cancer Therapeutics. Innovative biotherapeutics company, Hummingbird Bioscience,...
Gaining an appreciation for the drug discovery process and its prospects in a tech-led future. To meet medical needs, understanding the process of drug discovery is essential for the formulation of...
From Research Scientist to CEO, Dr Tomoyuki Igawa shares with us his scientific career and the challenges he faced along the way. I became a scientist because… I loved to create something new and...
